1. Home
  2. SNDL vs SGHT Comparison

SNDL vs SGHT Comparison

Compare SNDL & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SNDL Inc.

SNDL

SNDL Inc.

HOLD

Current Price

$1.36

Market Cap

312.4M

Sector

Health Care

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$9.47

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDL
SGHT
Founded
2006
2011
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.4M
309.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
SNDL
SGHT
Price
$1.36
$9.47
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$5.00
★ $9.08
AVG Volume (30 Days)
★ 1.1M
185.2K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 28.16
EPS
★ N/A
N/A
Revenue
N/A
★ $77,363,000.00
Revenue This Year
$6.19
$11.67
Revenue Next Year
$3.08
$10.39
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.17
$3.19
52 Week High
$2.89
$9.71

Technical Indicators

Market Signals
Indicator
SNDL
SGHT
Relative Strength Index (RSI) 51.39 78.57
Support Level $1.34 $4.43
Resistance Level $1.48 N/A
Average True Range (ATR) 0.04 0.36
MACD -0.00 0.07
Stochastic Oscillator 50.00 89.69

Price Performance

Historical Comparison
SNDL
SGHT

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: